Insider Selling: Billiontoone (NASDAQ:BLLN) CEO Sells 25,001 Shares of Stock

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 25,001 shares of Billiontoone stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the completion of the sale, the chief executive officer owned 16,667 shares in the company, valued at approximately $1,820,703.08. This trade represents a 60.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, November 2nd, Oguzhan Atay sold 5,334 shares of Billiontoone stock. The stock was sold at an average price of $113.17, for a total transaction of $603,648.78.
• On Wednesday, October 28th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $118.00, for a total transaction of $314,706.00.
• On Wednesday, October 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The shares were sold at an average price of $118.00, for a total transaction of $983,294.00.
• On Thursday, October 15th, Oguzhan Atay sold 5,150 shares of Billiontoone stock. The shares were sold at an average price of $100.23, for a total transaction of $516,184.50.
• On Wednesday, October 14th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total transaction of $261,366.00.
• On Wednesday, October 14th, Oguzhan Atay sold 3,183 shares of Billiontoone stock. The stock was sold at an average price of $98.34, for a total transaction of $313,016.22.
• On Monday, October 12th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $97.61, for a total transaction of $260,325.87.
• On Monday, October 12th, Oguzhan Atay sold 16,667 shares of Billiontoone stock. The shares were sold at an average price of $93.79, for a total value of $1,563,197.93.
• On Monday, September 28th, Oguzhan Atay sold 2,666 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $321,626.24.
• On Monday, September 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $1,005,293.12.

Billiontoone Stock Up 3.1%

Shares of NASDAQ:BLLN traded up $3.44 during trading on Wednesday, hitting $113.89. The stock had a trading volume of 582,091 shares, compared to its average volume of 469,134. The company has a market capitalization of $5.37 billion and a PE ratio of 157.79. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The firm’s fifty day moving average is $104.67 and its 200 day moving average is $96.89. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Analysts anticipate that Billiontoone, Inc. will post 0.80 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. reduced their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. BTIG Research dropped their price objective on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Guggenheim upped their price objective on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Canaccord Genuity Group started coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price for the company. Finally, Weiss Ratings cut Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $126.25.

Hedge Funds Weigh In On Billiontoone

Several large investors have recently modified their holdings of BLLN. Integrated Wealth Concepts LLC purchased a new stake in Billiontoone during the 2nd quarter valued at about $29,000. Parallel Advisors LLC increased its position in shares of Billiontoone by 86.7% during the third quarter. Parallel Advisors LLC now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. MCF Advisors LLC increased its position in shares of Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after acquiring an additional 344 shares in the last quarter. Family Legacy Financial Solutions LLC purchased a new position in Billiontoone in the 3rd quarter worth approximately $53,000. Finally, Provenance Wealth Advisors LLC purchased a new position in Billiontoone in the 3rd quarter worth approximately $56,000.

Billiontoone News Roundup

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 results topped expectations: Revenue was about $123.0 million, above the $115.8 million FactSet estimate. Reported earnings per share also exceeded the $0.16 consensus, although sources cite different actual EPS figures ($0.32 and $0.48). BillionToOne Q3 results and guidance
• Positive Sentiment: Higher 2026 revenue guidance: The company raised its full-year revenue outlook, signaling improved expectations for growth. Company announcement
• Negative Sentiment: Multiple insiders sold shares: The CEO, CTO and an SVP reported sales. The transactions were made under pre-arranged Rule 10b5-1 plans, which may temper—but do not eliminate—the bearish signal investors could take from insider selling. Insider transaction reports

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.